As DKD progresses, secondary mediators including growth factors, angiotensin-II and AGE activate inflammatory signalling pathways to further increase ROS production, inflammation, tubular cell hypertrophy and interstitial fibrosis [17–19, 21]. The gene discussed is AGT; the disease is diabetic kidney disease.